Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Non-alcoholic Fatty Liver Disease | 7 | 2025 | 75 | 1.100 |
Why?
|
| Diet, Western | 8 | 2025 | 45 | 1.000 |
Why?
|
| Obesity | 14 | 2020 | 699 | 0.960 |
Why?
|
| Prenatal Exposure Delayed Effects | 8 | 2025 | 136 | 0.780 |
Why?
|
| Liver | 14 | 2025 | 471 | 0.770 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 9 | 2016 | 26 | 0.760 |
Why?
|
| Fatty Liver | 7 | 2025 | 77 | 0.750 |
Why?
|
| Electron Transport Complex I | 1 | 2019 | 13 | 0.590 |
Why?
|
| Spectrophotometry | 1 | 2019 | 34 | 0.590 |
Why?
|
| Enzymes | 1 | 2019 | 23 | 0.590 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 5 | 2025 | 73 | 0.560 |
Why?
|
| Mitochondria | 5 | 2020 | 408 | 0.540 |
Why?
|
| Pregnancy | 18 | 2025 | 1254 | 0.540 |
Why?
|
| Gastrointestinal Microbiome | 4 | 2025 | 138 | 0.510 |
Why?
|
| Diabetes, Gestational | 4 | 2020 | 69 | 0.460 |
Why?
|
| Adiposity | 5 | 2022 | 94 | 0.400 |
Why?
|
| Liver Cirrhosis | 2 | 2025 | 78 | 0.380 |
Why?
|
| Inflammation | 6 | 2018 | 667 | 0.320 |
Why?
|
| Fatty Acids | 3 | 2017 | 218 | 0.300 |
Why?
|
| Pediatric Obesity | 2 | 2022 | 75 | 0.300 |
Why?
|
| Birth Weight | 2 | 2020 | 63 | 0.300 |
Why?
|
| Animals | 24 | 2025 | 10684 | 0.290 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2022 | 39 | 0.280 |
Why?
|
| Female | 23 | 2025 | 15624 | 0.280 |
Why?
|
| Muscle, Skeletal | 5 | 2016 | 639 | 0.270 |
Why?
|
| Receptors, Aryl Hydrocarbon | 2 | 2025 | 35 | 0.270 |
Why?
|
| Maternal Exposure | 3 | 2025 | 28 | 0.260 |
Why?
|
| Dietary Supplements | 3 | 2025 | 272 | 0.260 |
Why?
|
| Bile Acids and Salts | 2 | 2025 | 25 | 0.260 |
Why?
|
| Diet, High-Fat | 4 | 2022 | 144 | 0.250 |
Why?
|
| Oxidative Stress | 6 | 2022 | 677 | 0.240 |
Why?
|
| Mice | 15 | 2025 | 4802 | 0.240 |
Why?
|
| Kupffer Cells | 1 | 2025 | 11 | 0.240 |
Why?
|
| Insulin Resistance | 3 | 2015 | 176 | 0.240 |
Why?
|
| Lipid Metabolism | 5 | 2022 | 150 | 0.230 |
Why?
|
| Indoles | 1 | 2025 | 110 | 0.220 |
Why?
|
| Pregnancy Complications | 2 | 2018 | 112 | 0.220 |
Why?
|
| Lipoprotein Lipase | 2 | 2018 | 10 | 0.210 |
Why?
|
| Tryptophan | 1 | 2024 | 42 | 0.210 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2017 | 43 | 0.210 |
Why?
|
| Fenofibrate | 2 | 2016 | 8 | 0.200 |
Why?
|
| Male | 16 | 2025 | 13921 | 0.200 |
Why?
|
| Insulins | 1 | 2022 | 6 | 0.190 |
Why?
|
| Immunity, Innate | 1 | 2024 | 231 | 0.180 |
Why?
|
| Electron Transport | 2 | 2019 | 31 | 0.180 |
Why?
|
| PQQ Cofactor | 2 | 2022 | 7 | 0.180 |
Why?
|
| Infant, Newborn | 3 | 2020 | 916 | 0.170 |
Why?
|
| Infant Formula | 1 | 2020 | 18 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 1653 | 0.170 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2020 | 22 | 0.170 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 1507 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 3 | 2010 | 80 | 0.160 |
Why?
|
| Fatty Acid Desaturases | 1 | 2020 | 16 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 344 | 0.160 |
Why?
|
| Transgenes | 1 | 2020 | 63 | 0.160 |
Why?
|
| Placenta | 2 | 2018 | 78 | 0.160 |
Why?
|
| Breast Feeding | 1 | 2020 | 99 | 0.160 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2020 | 57 | 0.160 |
Why?
|
| Mothers | 3 | 2018 | 124 | 0.160 |
Why?
|
| Antioxidants | 2 | 2023 | 224 | 0.150 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2012 | 6 | 0.150 |
Why?
|
| Fetus | 2 | 2025 | 79 | 0.150 |
Why?
|
| Aconitate Hydratase | 1 | 2019 | 4 | 0.150 |
Why?
|
| Macrophages | 3 | 2024 | 305 | 0.150 |
Why?
|
| Gluconeogenesis | 4 | 2018 | 16 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 377 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 634 | 0.140 |
Why?
|
| Hypoxia | 1 | 2018 | 90 | 0.140 |
Why?
|
| Gene Expression | 2 | 2017 | 417 | 0.130 |
Why?
|
| Humans | 17 | 2025 | 28851 | 0.130 |
Why?
|
| Adipose Tissue | 3 | 2018 | 195 | 0.130 |
Why?
|
| Insulin | 4 | 2015 | 325 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2017 | 152 | 0.120 |
Why?
|
| Diet | 2 | 2016 | 241 | 0.120 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 5 | 0.120 |
Why?
|
| Diet, Diabetic | 1 | 2015 | 4 | 0.120 |
Why?
|
| Bone Marrow | 1 | 2016 | 83 | 0.120 |
Why?
|
| Atherosclerosis | 1 | 2016 | 97 | 0.110 |
Why?
|
| Hepacivirus | 2 | 2012 | 49 | 0.110 |
Why?
|
| Adenylate Kinase | 2 | 2014 | 8 | 0.110 |
Why?
|
| Cholesterol | 1 | 2016 | 203 | 0.110 |
Why?
|
| Response Elements | 2 | 2011 | 22 | 0.110 |
Why?
|
| Body Mass Index | 3 | 2022 | 412 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2014 | 56 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2014 | 72 | 0.110 |
Why?
|
| Mitochondrial Proteins | 1 | 2014 | 80 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2010 | 133 | 0.100 |
Why?
|
| Electron Transport Complex II | 1 | 2013 | 5 | 0.100 |
Why?
|
| Adult | 7 | 2022 | 8024 | 0.100 |
Why?
|
| Sirtuin 3 | 1 | 2013 | 18 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2013 | 71 | 0.100 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2013 | 22 | 0.100 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2012 | 5 | 0.100 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2012 | 7 | 0.100 |
Why?
|
| Mitochondria, Liver | 1 | 2012 | 12 | 0.100 |
Why?
|
| Anticholesteremic Agents | 1 | 2012 | 13 | 0.100 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2012 | 12 | 0.100 |
Why?
|
| Adipose Tissue, Brown | 1 | 2012 | 21 | 0.100 |
Why?
|
| Macrophage Activation | 1 | 2012 | 32 | 0.100 |
Why?
|
| Genome, Viral | 1 | 2012 | 34 | 0.090 |
Why?
|
| Primates | 2 | 2023 | 22 | 0.090 |
Why?
|
| Macaca | 2 | 2025 | 20 | 0.090 |
Why?
|
| Triglycerides | 4 | 2018 | 123 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2012 | 59 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2012 | 73 | 0.090 |
Why?
|
| Ceramides | 2 | 2025 | 33 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 2010 | 167 | 0.090 |
Why?
|
| Child | 3 | 2022 | 2287 | 0.090 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2010 | 5 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 94 | 0.080 |
Why?
|
| Mesoderm | 1 | 2010 | 16 | 0.080 |
Why?
|
| Adipocytes, White | 1 | 2010 | 10 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2011 | 88 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2010 | 27 | 0.080 |
Why?
|
| Infant | 3 | 2018 | 1025 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 22 | 0.080 |
Why?
|
| Receptors, Adiponectin | 1 | 2009 | 5 | 0.080 |
Why?
|
| Phenylbutyrates | 1 | 2009 | 3 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 247 | 0.080 |
Why?
|
| Interleukin-10 | 2 | 2024 | 74 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 135 | 0.070 |
Why?
|
| Adolescent | 3 | 2022 | 3193 | 0.070 |
Why?
|
| Biomarkers | 2 | 2022 | 776 | 0.070 |
Why?
|
| Glucose Tolerance Test | 3 | 2014 | 60 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2022 | 1280 | 0.060 |
Why?
|
| PPAR alpha | 2 | 2022 | 34 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2012 | 267 | 0.060 |
Why?
|
| Indoleacetic Acids | 1 | 2025 | 16 | 0.060 |
Why?
|
| Hepatic Stellate Cells | 1 | 2025 | 23 | 0.060 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2025 | 12 | 0.060 |
Why?
|
| Blood Glucose | 3 | 2015 | 310 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2017 | 380 | 0.060 |
Why?
|
| Cell Line, Tumor | 4 | 2012 | 1350 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 513 | 0.060 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2016 | 16 | 0.060 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2017 | 10 | 0.060 |
Why?
|
| Young Adult | 3 | 2017 | 2833 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 215 | 0.050 |
Why?
|
| Hyperglycemia | 1 | 2005 | 78 | 0.050 |
Why?
|
| Rats | 3 | 2012 | 1588 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 81 | 0.050 |
Why?
|
| PPAR gamma | 2 | 2016 | 29 | 0.050 |
Why?
|
| Endotoxins | 1 | 2022 | 30 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2012 | 874 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 465 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 142 | 0.050 |
Why?
|
| Uterus | 1 | 2021 | 31 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2017 | 427 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2012 | 25 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 157 | 0.040 |
Why?
|
| Lipids | 2 | 2016 | 218 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2016 | 1022 | 0.040 |
Why?
|
| Longevity | 1 | 2022 | 141 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2014 | 585 | 0.040 |
Why?
|
| Immune System | 1 | 2020 | 29 | 0.040 |
Why?
|
| Phenotype | 1 | 2023 | 685 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 272 | 0.040 |
Why?
|
| Cytokines | 2 | 2016 | 451 | 0.040 |
Why?
|
| Thapsigargin | 2 | 2010 | 8 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 61 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 1032 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 3 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2018 | 15 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 15 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2018 | 16 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 477 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2009 | 33 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 328 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 631 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2012 | 1469 | 0.030 |
Why?
|
| Bacteria | 1 | 2020 | 286 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 116 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2017 | 4 | 0.030 |
Why?
|
| Muscle Development | 1 | 2017 | 9 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2009 | 515 | 0.030 |
Why?
|
| Glucose | 2 | 2012 | 209 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2017 | 35 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 198 | 0.030 |
Why?
|
| Hypoglycemic Agents | 2 | 2008 | 110 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 40 | 0.030 |
Why?
|
| Metabolomics | 1 | 2017 | 87 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 2126 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 68 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2020 | 302 | 0.030 |
Why?
|
| Prediabetic State | 1 | 2016 | 10 | 0.030 |
Why?
|
| Foam Cells | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2016 | 5 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 21 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 31 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2016 | 25 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 38 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 65 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 739 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 22 | 0.030 |
Why?
|
| Glycemic Index | 1 | 2015 | 5 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2016 | 198 | 0.030 |
Why?
|
| Fasting | 1 | 2015 | 91 | 0.030 |
Why?
|
| Overweight | 1 | 2015 | 114 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2017 | 485 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 463 | 0.030 |
Why?
|
| Glutathione | 1 | 2013 | 76 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2012 | 22 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 58 | 0.020 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2012 | 5 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 3 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 58 | 0.020 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 12 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2012 | 29 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2012 | 28 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2012 | 21 | 0.020 |
Why?
|
| Proteomics | 1 | 2014 | 197 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 35 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 30 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 22 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2012 | 20 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 54 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 87 | 0.020 |
Why?
|
| Virus Replication | 1 | 2012 | 66 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 120 | 0.020 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2011 | 19 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 31 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2011 | 27 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2012 | 344 | 0.020 |
Why?
|
| Adipocytes, Brown | 1 | 2010 | 2 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 255 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 53 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 126 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 194 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2010 | 96 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2009 | 22 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2009 | 3 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 20 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 165 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2008 | 12 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 467 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 111 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 667 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 101 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 737 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 469 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 2007 | 4 | 0.020 |
Why?
|
| Choline Deficiency | 1 | 2007 | 5 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2007 | 7 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 472 | 0.020 |
Why?
|
| Lipase | 1 | 2007 | 10 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2007 | 20 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2007 | 6 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2007 | 29 | 0.020 |
Why?
|
| Palmitates | 1 | 2007 | 9 | 0.020 |
Why?
|
| Methionine | 1 | 2007 | 38 | 0.020 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Metformin | 1 | 2007 | 36 | 0.020 |
Why?
|
| Body Composition | 1 | 2008 | 267 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 5598 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2007 | 191 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2008 | 668 | 0.020 |
Why?
|
| Body Weight | 1 | 2007 | 250 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 251 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2007 | 215 | 0.010 |
Why?
|
| Cell Line | 1 | 2007 | 700 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 7414 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 612 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 1613 | 0.010 |
Why?
|